Correction to: miRNA-23b as a biomarker of culture-positive neonatal sepsis

Affiliations

Ahlam Fatmi: Laboratory of Applied Molecular Biology and Immunology
Sid Ahmed Rebiahi: Laboratory of Microbiology Applied in Food, Biomedical and Environment
Nafissa Chabni: Faculty of Medicine, Tlemcen Medical Centre University
Hanane Zerrouki: Laboratory of Microbiology Applied in Food, Biomedical and Environment
Hafsa Azzaoui: Laboratory of Applied Molecular Biology and Immunology
Yamina Elhabiri: Laboratory of Microbiology Applied in Food, Biomedical and Environment
Souheila Benmansour: Laboratory of Applied Molecular Biology and Immunology
José Santiago Ibáñez-Cabellos: Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III
Mohammed Chems-Eddine Smahi: Laboratory of Applied Molecular Biology and Immunology
Mourad Aribi: Laboratory of Applied Molecular Biology and Immunology
José Luis García-Giménez: Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III
Federico V. Pallardó: Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III

Abstract

An amendment to this paper has been published and can be accessed via the original article.

ISSN: 1076-1551 (Print); 1528-3658 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Therapeutics. Pharmacology; Science: Chemistry: Organic chemistry: Biochemistry
Website: https://molmed.biomedcentral.com